Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary Stenosis
Status:
Completed
Trial end date:
2017-04-18
Target enrollment:
Participant gender:
Summary
The aim of the present study is to evaluate the effect of treatment with Liraglutide on the
coronary microvasculature and angina symptoms, in overweight patients with microvascular
dysfunction and angina pectoris but no coronary artery stenosis.